• Firm Profile
  • Management
  • Awards & Honors
  • Our Offices


      Luke joined NTD in 2002.  Before then, he had been working as a physician in Department of Internal Medicine and then Department of Hematology of PUMC Hospital for nine years and participated in a series of study focusing on the pathogenesis and treatment of hematologic malignancies during 1998-2000 at National Laboratory of Medical Molecular Biology, CAMS & PUMC.  After he switched to IP in 2002, Luke has handled over a thousand of patent applications in life sciences, pharmaceuticals, and related areas.  Luke represents a full range of clients, from domestic start-ups to MNCs, including some top universities and research institutes in China.  He has extensive experiences in patent mining and drafting, filing strategy advising, prosecution and reexamination, patentability and validity assessment, FTO search and analysis, and consulting.  Luke is also experienced in patent litigation and has represented clients in a number of invalidation cases and patent administrative lawsuits.  He frequently gives IP trainings and lectures for domestic clients and introductions on new trends in Chinese patent practice for foreign clients.  He is also a frequent speaker in IP seminars and conferences both in China and abroad, and his most recent presentation is at AIPLA Meeting (Minneapolis, May 2016), the topic of which is “Chinese perspective in protection of medical diagnostics”).  Luke is highly appraised by both foreign and domestic clients for the excellent IP legal services provided by his team.

    Education and Training:

      • M.D., Chinese Academy of Medical Sciences & Peking Union Medical College
      • B.S., Medicine, Shanghai Medical University

    Technical Areas:

      Life sciences; Biotechnology; Pharmaceuticals; Medical diagnostics and therapeutics; Antibody engineering; Vaccines; and genetic engineering, etc.

    Professional Affiliations:

      All-China Patent Attorneys Association (ACPAA) 

    Working Language:

      English, Mandarin

    Representative cases:

      • Pfizer Inc. vs. a Chinese pharmaceutical company, patent invalidation, representative of the Patentee
      • ABZYMO Biosciences vs. AXIS-SHIELD, patent invalidation, representative of the Requestor
      • SCA Hygiene Products AB vs. Patent Reexamination Board, administrative lawsuits, representative of the Plaintiff

    Selected Seminars & Events:

      • AIPLA Spring Meeting (Minneapolis, May 2016), “Chinese perspective in protection of medical diagnostics”